DTaP-IPV-Hep B-PRP-T hexavalent vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTaP-IPV-Hep B-PRP-T hexavalent vaccine, covering 2022-04-06 to 2022-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine. [Phase 3]